Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Malignant Lymphoma

  Free Subscription


2 Blood
2 Bone Marrow Transplant
1 Br J Haematol
2 Cancer
1 Eur J Haematol
2 Haematologica
1 Lancet Oncol
3 Leuk Lymphoma
2 Leukemia

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. ADVANI RH, Skrypets T, Civallero M, Spinner MA, et al
    Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.
    Blood. 2021;138:213-220.
    PubMed         Abstract available

  2. PIGNARRE A, Chatonnet F, Caron G, Haas M, et al
    Plasmablasts derive from CD23- activated B cells after the extinction of IL-4/STAT6 signaling and IRF4 induction.
    Blood. 2021;137:1166-1180.
    PubMed         Abstract available

    Bone Marrow Transplant

  3. LEW TE, Cliff ERS, Dickinson M, Tam CS, et al
    T-cell replete allogeneic stem cell transplant for mantle cell lymphoma achieves durable disease control, including against TP53-mutated disease.
    Bone Marrow Transplant. 2021 Jul 20. pii: 10.1038/s41409-021-01418.

  4. LOWENBERG B, Kersten MJ, Gale RP, van Oers M, et al
    Professor Anton Hagenbeek 1948-2021: Father of MRD and lymphoma expert.
    Bone Marrow Transplant. 2021 Jul 19. pii: 10.1038/s41409-021-01375.

    Br J Haematol

  5. MOIA R, Favini C, Ferri V, Forestieri G, et al
    Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma.
    Br J Haematol. 2021 Jul 22. doi: 10.1111/bjh.17718.
    PubMed         Abstract available


  6. JUWEID ME, Mueller M, Alhouri A, A-Risheq MZ, et al
    Positron emission tomography/computed tomography in the management of Hodgkin and B-cell non-Hodgkin lymphoma: An update.
    Cancer. 2021 Jul 19. doi: 10.1002/cncr.33772.
    PubMed         Abstract available

  7. HU B, Boselli D, Pye LM, Chen T, et al
    Equal access to care and nurse navigation leads to equitable outcomes for minorities with aggressive large B-cell lymphoma.
    Cancer. 2021 Jul 21. doi: 10.1002/cncr.33779.
    PubMed         Abstract available

    Eur J Haematol

  8. METZNER B, Pott C, Muller TH, Casper J, et al
    Long-term outcome in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation.
    Eur J Haematol. 2021 Jul 20. doi: 10.1111/ejh.13691.
    PubMed         Abstract available


  9. DODERO A, Guidetti A, Marino F, Tucci A, et al
    Dose-Adjusted Epoch and Rituximab for the treatment of double expressor and double hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome.
    Haematologica. 2021 Jul 22. doi: 10.3324/haematol.2021.278638.
    PubMed         Abstract available

  10. LIN RJ, Owens CN, Drill E, Iannotta A, et al
    Prephase rituximab/prednisone therapy and aging-related, pro-inflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma
    Haematologica. 2021 Jul 22. doi: 10.3324/haematol.2021.278719.
    PubMed         Abstract available

    Lancet Oncol

  11. MARRA A, Adamo F, Baldoni S, Laurenti ME, et al
    Richter's transformation in the heart.
    Lancet Oncol. 2021;22:e341.

    Leuk Lymphoma

  12. DURANI U, Ansell SM
    CD5+ diffuse large B-cell lymphoma: a narrative review.
    Leuk Lymphoma. 2021 Jul 21:1-9. doi: 10.1080/10428194.2021.1953010.
    PubMed         Abstract available

  13. WITTMANN DAYAGI T, Sherman G, Bielorai B, Adam E, et al
    Characteristics and risk factors of infections following CD28-based CD19 CAR-T cells.
    Leuk Lymphoma. 2021;62:1692-1701.
    PubMed         Abstract available

  14. MANSO R, Rodriguez-Perales S, Torres-Ruiz R, Santonja C, et al
    PD-L1 expression in peripheral T-cell lymphomas is not related to either PD-L1 gene amplification or rearrangements.
    Leuk Lymphoma. 2021;62:1648-1656.
    PubMed         Abstract available


  15. LOWENBERG B, Kersten MJ, Gale RP, van Oers M, et al
    Prof. Anton Hagenbeek 1948-2021: Father of MRD and Lymphoma Expert.
    Leukemia. 2021 Jul 20. pii: 10.1038/s41375-021-01310.

  16. ZHANG Y, Wang Y, Liu Y, Tong C, et al
    Long-term activity of tandem CD19/CD20 CAR therapy in refractory/relapsed B-cell lymphoma: a single-arm, phase 1-2 trial.
    Leukemia. 2021 Jul 16. pii: 10.1038/s41375-021-01345.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.